E-mail: petr.cetkovsky@uhkt.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikované knihy
Publikovaná abstrakta
- A Limited Impact of Chemotherapy on Prolonged Survival in Myelodysplasia (MDS). An Analysis of 142 Patients with Advanced Disease.
- ABNORMALITY OF GLUCOSE AND LIPID METABOLISM DURING NILOTINIB THERAPY – RESULTS OF ENIGMA 2 STUDY
- ALLOGENEIC TRANSPLANTATION FOR MYELOFIBROSIS IN MYELOPROLIFERATIVE DISEASE -A SINGLE CENTER EXPERIENCE
- ALLOGENEIC TRANSPLANTATION IN ADVANCED STAGES OF CML IN THE THIRD MILLENIUM. IS THERE A DIFFERENCE ?
- ANALYSIS OF 1458 ACUTE MYELOID LEUKEMIA FROM THE ALERT PROJECT (ACUTE LEUKEMIA CLINICAL REGISTER) IN THE CZECH REPUBLIC IN 1996-2006
- ANALYSIS OF CMV SPECIFIC IMMUNITY RECONSTITUTION IN PATIENTS FOLLOWING ALLOGENIC STEM CELL TRANSPLANTATION BY TETRAMER TECHNOLOGY
- ANALYSIS OF TREATMENT OUTCOME OF ALL PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL): NO DIFFERENCE IN SURVIVAL BEFORE AND AFTER ATRA ERA
- ARE FLT3 ITD AND D835 MUTATIONS SUFFICIENT INDICATORS FOR ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA? AN ANALYSIS OF PATIENTS FROM THE CZECH ACUTE LEUKEMIA CLINICAL REGISTER (ALERT)
- ASSESSMENT OF CMV SPECIFIC IMMUNITY BY FLOW CYTOMETRY USING A COMBINED APPROACH OF SPECIFIC CMV CELL ENUMERATION AND FUNCTIONAL T CELL ANALYSIS
- CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia
- Clinical Manifestation of 1000 Leukemias
- CLOSTRIDIUM DIFFICILE INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY IN CZECH AND SLOVAK REPUBLIC – A RETROSPECTIVE ANALYSIS
- COMBINATION CHEMOTHERAPY IN MDS: A LIMITED IMPACT ON SURVIVAL AS A SINGLE THERAPY, A BENEFICIAL EFFECT ON OUTCOME OF SUBSEQUENT TRANSPLANTATION
- Combination Chemotherapy Leading In Advanced MDS Patients to a Rapid Clearence of Bone Marrow Blasts Prior Stem Cell transplantation (SCT) Is Superior to up-Front SCT Even with Intensified Conditioning for Long-Term Survival
- COMPARISON OF GALACTOMANNAN DETECTED IN SERUM/ BRONCHOALVEOLAR LAVAGE FLUID AND TYPE OF ABNORMALITY ON PULMONARY HIGH RESOLUTION COMPUTER TOMOGRAPHY IN PATIENTS WITH PULMONARY INVASIVE ASPERGILLOSIS
- Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study
- DASATINIB EFFICACY AND TOLERANCE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT/INTOLERANT TO IMATINIB IN THE CONTEXT OF REAL CLINICAL PRACTICE MANAGEMENT
- DASATINIB EVEN AT LOWER DOSES IS AN EFFECTIVE FOR CHRONIC MYELOID LEUKAEMIA TREATMENT IN PATIENTS RESISTANT OR INTOLERANT TO IMATINIB
- DIFFERENTIAL DNA METHYLATION IN AML PATIENTS WITH WILD-TYPE AND MUTATED DNMT3A AND PROGNOSTIC IMPACT OF DNA METHYLATION
- DNMT3A MUTATIONS IN INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA
- EFFICACY AND SAFETY OF IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. AN ANALYSIS OF A COMPREHENSIVE POPULATION-BASED DATABASE
- ESTIMATION OF THE CURRENT SURVIVAL MEASURES IN CHRONIC MYELOID LEUKEMIA: METHODOLOGY AND NEW SOFTWARE TOOLS
- EXPRESSION LEVELS OF WT1 AND NPM1 AND NOVEL NONSPECIFIC MARKERS AS TOOLS FOR EVALUATING MINIMAL RESIDUAL DISEASE IN AML
- FIND ´FUNGAL INFECTION DATABASE´ - RETROSPECTIVE ANALYSIS OF INVASIVE ASPERGILLOSIS IN HEMATOONCOLOGICAL DEPARTMENTS IN CZECH AND SLOVAK REPUBLIC BETWEEN 2001-2009
- FLT3 TYROSINE KINASE DOMAIN (TKD) MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
- IDH1 (BUT NOT IDH2) MUTATIONS CAUSE INFERIOR OUTCOME IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETICS
- IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. CAN WE COMPARE THE REAL-LIFE DATA TO CLINICAL TRIAL RESULTS?
- IMATINIB IN THE FIRST-LINE CML TREATMENT: AN ANALYSIS OF A COMPREHENSIVE NON-COMMERCIAL DATABASE OF ALL CONSECUTIVE PATIENTS IN A DEFINED POPULATION
- Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin
- INCIDENCE OF INVASIVE ASPERGILLOSIS (IA) IN A TERTIARY HEMATOLOGICAL CENTRE IN CZECH REPUBLIC, EVALUATION OF THE GALACTOMANNAN MONITORING
- Model klinického registru umožňujícího hodnocení léčebné péče: projekt ALERT (Akutní LEukémie – klinický RegisTr)
- Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts
- MRD LEVEL ANALYSIS IN ADULT ALL PATIENTS. ANALYSIS OF THE CZECH LEUKEMIA STUDY GROUP–FOR LIFE (CELL)
- MUTATIONS OF ASXL1 GENE IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETIC PROFILE
- NEW PROGNOSTIC MARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN THE EVERYDAY HEMATOLOGICAL PRACTICE. A MULTICENTER ANALYSIS
- PERFORMANCE CHARACTERISTICS OF CONSENSUAL APPROACHES FOR SMALL AND MINOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONE DETERMINATION BY FLOW CYTOMETRY
- PREDICTION OF IMATINIB THERAPY RESPONSE: A ROLE OF INTRACELLULAR TRANSPORTERS HOCT-1 AND ABCB1
- QUANTITATIVE MONITORING OF WT1 GENE EXPRESSION IN PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA - AN USEFUL TOOL FOR EARLY DETECTION OF MINIMAL RESIDUAL DISEASE
- SECONDARY GENETIC ABERRATIONS AND THEIR EFFECT ON PROGNOSIS IN CORE BINDING FACTOR - ACUTE MYELOID LEUKEMIA (CBF-AML)
- SERIOUS EBV ENCEPHALITIS IN PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) – SERIES OF 3
- SUCCESSFUL MANAGEMENT OF CML DURING PREGNANCY AND IN POST-PARTUM PERIOD
- THE DIFFERENCES IN PROGNOSTIC OUTCOME BETWEEN AML1/ETO AND CBFb/MYH11 POSITIVE AML PATIENTS
- The Gene Expressions of hOCT1 and ABCB1 Change During the Course of CML in Relation to Imatinib Therapy
- THE IMPACT OF LENGTH AND INTEGRATION SITE OF THE INTERNAL TANDEM DUPLICATION OF FLT3 GENE ON THE CLINICAL OUTCOME OF PATIENTS WITH AML
- THREE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIAS (CBF-AML) IN A SINGLE PATIENT
- TWO YEARS WITH PANDEMIC H1N1 2009 INFLUENZA A IN A TERTIARY HEMATOLOGY DEPARTMENT
- WHOLE GENOME AND TARGETED BISULFITE SEQUENCING REVEALS 3 DNA METHYLATION CLUSTERS AND NEW BIOLOGICALLY RELEVANT HYPERMETHYLATED GENES IN AML PATIENTS
Články v Klinické onkologii
- Difúzní B – velkobuněčný lymfom projevující se jako autoimunní hemolytická anemie. Diagnostická úskalí
- Diseminovaná intravaskulární koagulace u malignit
- Indikace k alogenním a autologním transplantacím krvetvorných buněk. Doporučení České hematologické společnosti ČLS JEP a České onkologické společnosti ČLS JEP.
- Mobilizace hematopoetických kmenových buněk a možné postupy u tzv. obtížně mobilizovatelných nemocných
- Mobilizace kmenových buněk krvetvorby u nemocných se zhoubnými nádory varlat před plánovanou léčbou vysokými dávkami chemoterapie
- Model populačního klinického registru umožň ujícího hodnocení léčebné péče: projekt ALERT (akutní leukemie-klinický registr)
- Odchylky v krevním obraze a poruchy hemostázy u pacientů se solidními tumory – přehled a popis případů
- Předběžné zkušenosti s léčbou resistentního maligního lymfogranulomu kombinací lomustin, etoposid, vinblastin a dexamethason
- Retrospektivní analýza dvou druhů antibakteriální profylaxe u nemocných po alogenní transplantaci kostní dřeně: fluorochinolon plus trimethoprim/sulfametoxazol versus fluorochinolon v monoterapii
- Trombotické komplikace a pretrombotické stavy u nemocných s malignitami
- Vysoké dávky chemoterapie s transplantací autologních kmenových buněk v léčbě nemocných se zhoubnými nádory varlat
- Zpráva o stáži na jednotce pro transplantace kostní dřeně na I. interní klinice ve Vídni
- Zpráva z 5.mezinárodního sympozia o léčbě akutních leukémií
